Gregory Martini
Chief Financial OfficerMr. Gregory Martini, also known as Greg, serves as Chief Financial Officer at Kyverna Therapeutics, Inc. since May 18, 2026. He was CFO & Investor Realtions of Ironwood Pharmaceuticals, Inc. from January 27, 2025 until May 15, 2026 & served as its Head of Investor Realtions and Senior Vice President until May 15, 2026. He was Vice President of Strategic Finance of Ironwood Pharmaceuticals, Inc. until January 2025. Mr. Martini joined Ironwood in 2017 and previously served as Senior Director, Financial Planning & Analysis from 2020 to 2022 and as Director, Financial Planning & Analysis from 2019 to 2020. Prior thereto, he served in various financial planning & analysis roles of increasing responsibility enterprise-wide, supporting the commercial, research and development and general and administrative functions. Before joining the Company, Mr. Martini served in various financial and corporate development roles at Thermo Fisher Scientific, Ernst & Young LLP and Raytheon Technologies. Mr. Martini holds a B.S. in finance from Bentley University.
Positions
- Company NameKyverna Therapeutics, Inc.Stock CodeKYTXPositionChief Financial Officer
